Search Results

There are 14449 results for: content related to: Progression of motor and nonmotor features of Parkinson's disease and their response to treatment

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease

    British Journal of Clinical Pharmacology

    Volume 74, Issue 2, August 2012, Pages: 284–295, Thuy C. Vu, John G. Nutt and Nicholas H. G. Holford

    Version of Record online : 10 JUL 2012, DOI: 10.1111/j.1365-2125.2012.04208.x

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  4. Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline

    Movement Disorders

    Volume 26, Issue 13, November 2011, Pages: 2316–2323, Peter Jenner and J. William Langston

    Version of Record online : 23 SEP 2011, DOI: 10.1002/mds.23926

  5. You have free access to this content
    Clinical pharmacology = disease progression + drug action

    British Journal of Clinical Pharmacology

    Volume 79, Issue 1, January 2015, Pages: 18–27, Nick Holford

    Version of Record online : 19 DEC 2014, DOI: 10.1111/bcp.12170

  6. Monoamine oxidase B inhibitors for early Parkinson's disease

    Intervention Review

    The Cochrane Library

    Kristian Turnbull, Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe and Carl Counsell

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD004898.pub2

  7. Monoamine Oxidase-B Inhibition in the Treatment of Parkinson's Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 12P2, December 2007, Pages: 174S–185S, Dr. Hubert H. Fernandez and Dr. Jack J. Chen

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.12part2.174S

  8. Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysis

    Pharmaceutical Statistics

    Volume 8, Issue 3, July/September 2009, Pages: 225–238, Berend Arnold Ploeger and Nicholas H. G. Holford

    Version of Record online : 24 NOV 2008, DOI: 10.1002/pst.355

  9. You have free access to this content
    Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration

    Journal of Neurochemistry

    Volume 105, Issue 5, June 2008, Pages: 1970–1978, Wen Zhu, Wenjie Xie, Tianhong Pan, Joseph Jankovic, Jun Li, Moussa B. H. Youdim and Weidong Le

    Version of Record online : 8 MAR 2008, DOI: 10.1111/j.1471-4159.2008.05330.x

  10. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  11. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  12. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics

    Movement Disorders

    Volume 23, Issue 15, 15 November 2008, Pages: 2194–2201, C. Warren Olanow, Robert A. Hauser, Joseph Jankovic, William Langston, Anthony Lang, Werner Poewe, Eduardo Tolosa, Fabrizio Stocchi, Eldad Melamed, Eli Eyal and Olivier Rascol

    Version of Record online : 19 OCT 2008, DOI: 10.1002/mds.22218

  13. Effects of combined treatment with clorgyline and selegiline on extracellular noradrenaline and serotonin levels

    Acta Neuropsychiatrica

    Volume 24, Issue 6, December 2012, Pages: 369–373, Yuji Kitaichi, Takeshi Inoue, Shin Nakagawa, Shuken Boku and Tsukasa Koyama

    Version of Record online : 12 MAR 2012, DOI: 10.1111/j.1601-5215.2012.00652.x

  14. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  15. You have free access to this content
    How should we treat a patient with early Parkinson’s disease?

    International Journal of Clinical Practice

    Volume 64, Issue 9, August 2010, Pages: 1210–1219, S. Tsouli and S. Konitsiotis

    Version of Record online : 13 JUL 2010, DOI: 10.1111/j.1742-1241.2010.02371.x

  16. You have full text access to this OnlineOpen article
    A Time to Event Tutorial for Pharmacometricians

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 2, Issue 5, May 2013, Pages: 1–8, Nick Holford

    Version of Record online : 15 MAY 2013, DOI: 10.1038/psp.2013.18

  17. Interpreting the results of Parkinson's disease clinical trials: Time for a change

    Movement Disorders

    Volume 26, Issue 4, March 2011, Pages: 569–577, Nick H. G. Holford and John G. Nutt

    Version of Record online : 2 MAR 2011, DOI: 10.1002/mds.23555

  18. Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?

    Movement Disorders

    Volume 26, Issue 7, June 2011, Pages: 1187–1193, Carl E. Clarke, Smitaa Patel, Natalie Ives, Caroline Rick, Keith Wheatley and Richard Gray

    Version of Record online : 14 APR 2011, DOI: 10.1002/mds.23519

  19. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  20. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x